medigraphic.com
ISSN 2448-5640 (Print)
Diario Oficial de la Sociedad Mexicana de Cirugía Cardiaca, A.C., y del Colegio Mexicano de Cirugía Cardiovascular y Torácica, A.C.

2016, Number 4

<< Back Next >>

Cir Card Mex 2016; 1 (4)

Asistencia circulatoria mecánica con sistema de oxigenación por membrana extracórporea para el tratamiento del choque cardiogénico secundario a miocarditis fulminante

Sánchez-Medina FF, Salazar-Rascón C, Carrillo-Ramos P, Leyva D, Cossío-Méndez G, Celaya-Cota M, López-Larios A, Virgen-Carrillo LR, Cortés-Lawrenz J, Siordia-Zamorano RE

Language: Spanish
References: 24
Page: 149-152
PDF size: 209.98 Kb.


ABSTRACT

Mechanical circulatory support is a great utility in life-threatening refractory cardiogenic shock of any cause. It allows taking diverse decision-making therapies to patient recovery. We report the case of a fifth-decade life man with clinical setting of severe airway infection followed by acute heart failure and irreversible cardiogenic shock secondary to fulminant myocarditis, stabilized undergone mechanical circulatory support and extra-corporeal membrane oxigenation. One year later, he is totally integrated to normal life. We state the importance of early circulatory support for potential recovery of myocardial function.


REFERENCES

  1. Ariza SA, Sánchez SJC, Lorente TV, et al. Asistencia ventricular con membranade oxigenación extracorpórea; una nueva alternativa al rescate deshock cardiogénigo refractario. Rev Esp Cardiol 2013; 66:501-3.

  2. Díez VP, Sousa I, Núñez A, et al. Tratamiento precoz del shock cardiogénicorefractario mediante implante percutáneo de ECMO veno-arterial en el laboratoriode hemodinámica. Rev Esp Cardiol 2014; 67:1059-61.

  3. Slaughter MS, Singh R. El Papel de los dispositivos de asistencia ventricularen la insuficiencia cardíaca avanzada. Rev Esp Cardiol 2012; 65:982-5.

  4. Belohlavek J, Rohn V, Jansa P, et al. Veno-arterial ECMO in severe acuteright failure with pulmonary obstructive hemodynamic pattern. J InvasiveCardiol 2010; 22:365-9.

  5. Fux T, Svenarud P, Rinnemo KH, et al. Extracorporeal membrane oxigenationas a rescue of intractable ventricular fibrillation and bridge to hearttransplantation Eur J Heart Fail 2010; 12:301-4.

  6. Dariush M, Emelia JB, Donna KA, et al. Heart disease and stroke statistics—2015 Update: A report from the American Heart Association. Circulation2015; 131:e269-70.

  7. Rihal CS, Naidu SS, Givertz MM, et al. Expert consensus statement on theuse of percutaneous mechanical circulatory support devices in cardiovascularcare. JACC 2015; 65:e7-26.

  8. McIver J, Ross HJ. Quality of life and left ventricular assist device support.Circulation 2012; 126:866-74.

  9. Kirklin J, Naftel D, Pagani F, et al. Sixth INTERMACS annual report: a

  10. 10,000-patient database. J Heart Lung Transplant 2014; 33:555-64.10. De By TM, Mohacsi P, Gummert J, Bushnaq H, et al. The European Registryfor patients with mechanical circulatory support (EUROMACS): first annualreport. Eur J Cardiothoracic Surg 2015; 47:770-6.

  11. Strueber M, Larbalestier R, Jansz P, et al. Results of the post-market Registryto Evaluate the HeartWare Left Ventricular Assist System (ReVOLVE). JHEART Lung Transplant 2014; 33:486-91.

  12. Park SJ, Tector A, Piccioni W, et al. Left ventricular assist devices as destinationtherapy: a new look at survival. J Thorac Cardiovasc Surg 2005;129:9-17.

  13. Torregrosa S, Fuset MP, Castelló A, et al. Oxigenación de mambrana extracorporealpara soporte cardíaco ó respiratorio en adultos. Cir Cardiov 2009;16:163-77.

  14. Doll N, Fabricius A, Borger MA, et al. Temporary estracorporeal membraneoxygenation in patients with refractory postoperative shock – a single centerexperience. J Card Surg 2003; 18:512-8.

  15. Peek GJ, Killer HM, Reeves R, Sosnowski AW, Firmin RK. Early experiencewith a polymetil-pentene oxigenator for adult extracorporeal life support.ASAIO J 2002; 48:480-2.

  16. Horton S, Thuys C, Bennett M, Agustín S, Rosenberg M, Brizard C. Experiencewith the Jostra Rotaflow and QuadroxD oxigenator for ECMO. Perfusion2004; 19:17-23.

  17. Hoefer D, Ruttmann E, Poelz G, et al. Outcome evaluation of the bridge-tobridgeconcept in patients with cardiogenic shock. Ann Thorac Surg 2006;82:28-33.

  18. Yacoub MH. A novel strategy to maximize the efficacy of left ventricular assistdevices as a bridge to recovery. Eur Heart J 2001; 22:534-40.

  19. Ibsen LM, Bratton SL. Fulminant myocarditis and extracorporeal membraneoxygenation: what we know, what is there still to learn? Crit CareMed 2010; 38:686-688.

  20. Birks EJ, Transley PD, Hardy J, et al. Left ventricular assist device and drugtherapy for the reversal of heart failure. N Engl J Med 2006; 355:1873-84.

  21. Kindermann I, Barth C, Mahfoud F, et al. Update on Myocarditis. JACC2012; 59:779–92.

  22. Duncan BW, Bohn DJ, Atz AM, et al. Mechanical circulatory support for thetreatment of children with acute fulminant myocarditis. J Thorac CardiovascSurg 2001; 122:440-8.

  23. McCarthy RE, Boehmer JP, Hruban RH, et al. Long-term outcome of fulminantmyocarditis as compared with acute (Nonfulminant) myocarditis. NEngl J Med 2000; 342:690-5.

  24. Ning B, Zhang C, Lin R, et al. Local experience with extracorporeal membraneoxygenation in children with acute fulminant myocarditis. PloS ONE8(12): e82258.doi:10.1371/journal.pone.0082258.




2020     |     www.medigraphic.com